| 臺大學術典藏 |
2020-12-02T02:34:36Z |
TREM-1 expression in tumor-associated macrophages and clinical outcome in lung cancer
|
Ho C.-C.;Liao W.-Y.;Wang C.-Y.;Lu Y.-H.;Huang H.-Y.;Chen H.-Y.;Chan W.-K.;Chen H.-W.;Pan-Chyr Yang; Ho C.-C.; Liao W.-Y.; Wang C.-Y.; Lu Y.-H.; Huang H.-Y.; Chen H.-Y.; Chan W.-K.; Chen H.-W.; PAN-CHYR YANG |
| 臺大學術典藏 |
2020-12-02T02:33:59Z |
Endobronchial ultrasound-guided transbronchial biopsy of peripheral pulmonary lesions: How many specimens are necessary?
|
Wu P.-C.; Ho C.-C.; Yu C.-J.; PAN-CHYR YANG; Huang C.-T.; Tsai Y.-J.; Liao W.-Y. |
| 臺大學術典藏 |
2020-12-02T02:33:49Z |
Survival of lung adenocarcinoma patients with malignant pleural effusion
|
Wu S.-G.; Yu C.-J.; Tsai M.-F.; Liao W.-Y.; Yang C.-H.; Jan I.-S.; PAN-CHYR YANG; Shih J.-Y.; Wu S.-G.; Yu C.-J.; Tsai M.-F.; Liao W.-Y.; Yang C.-H.; Jan I.-S.; PAN-CHYR YANG; Shih J.-Y. |
| 臺大學術典藏 |
2020-12-02T02:33:46Z |
Multi-gene analyses from waste brushing specimens for patients with peripheral lung cancer receiving EBUS-assisted bronchoscopy
|
Tsai T.-H.; Yang C.-Y.; Ho C.-C.; Liao W.-Y.; Jan I.-S.; Chen K.-Y.; Wang J.-Y.; Ruan S.-Y.; Yu C.-J.; Yang J.C.H.; PAN-CHYR YANG; Shih J.-Y.; Tsai T.-H.; PAN-CHYR YANG et al. |
| 臺大學術典藏 |
2020-12-02T02:33:46Z |
Anxiety, depression and related factors in family caregivers of newly diagnosed lung cancer patients before first treatment
|
Lee Y.-H.; Liao Y.-C.; Liao W.-Y.; Shun S.-C.; Liu Y.-C.; Chan J.-C.; Yu C.-J.; PAN-CHYR YANG; Lai Y.-H.; Lee Y.-H.; Liao Y.-C.; Liao W.-Y.; Shun S.-C.; Liu Y.-C.; Chan J.-C.; Yu C.-J.; PAN-CHYR YANG; Lai Y.-H. |
| 臺大學術典藏 |
2020-12-02T02:33:41Z |
Quality of life and related factors in patients with newly diagnosed advanced lung cancer: A longitudinal study
|
Liao Y.-C.;Shun S.-C.;Liao W.-Y.;Yu C.-J.;Pan-Chyr Yang;Lai Y.-H.; Liao Y.-C.; Shun S.-C.; Liao W.-Y.; Yu C.-J.; PAN-CHYR YANG; Lai Y.-H. |
| 臺大學術典藏 |
2020-12-02T02:33:34Z |
Heparin co-factor II enhances cell motility and promotes metastasis in non-small cell lung cancer
|
Liao W.-Y.; Ho C.-C.; Hou H.-H.; Hsu T.-H.; Tsai M.-F.; Chen K.-Y.; Chen H.-Y.; Lee Y.-C.; Yu C.-J.; Lee C.-H.; Pan-Chyr Yang; Liao W.-Y.; PAN-CHYR YANG et al. |
| 臺大學術典藏 |
2020-12-02T02:33:31Z |
Identification of Five Driver Gene Mutations in Patients with Treatment-Na?ve Lung Adenocarcinoma in Taiwan
|
Hsu K.-H.; Ho C.-C.; Hsia T.-C.; Tseng J.-S.; Su K.-Y.; Wu M.-F.; Chiu K.-L.; Yang T.-Y.; Chen K.-C.; Ooi H.; Wu T.-C.; Chen H.-J.; Chen H.-Y.; Chang C.-S.; Hsu C.-P.; Hsia J.-Y.; Chuang C.-Y.; Lin C.-H.; Chen J.J.W.; Chen K.-Y.; Liao W.-Y.; Shih J.-Y.; Yu S.-L.; Yu C.-J.; Pan-Chyr Yang; Chang G.-C.; Hsu K.-H.; PAN-CHYR YANG et al. |
| 臺大學術典藏 |
2020-12-02T02:33:29Z |
EGFR mutation and lobar location of lung adenocarcinoma
|
Tseng C.-H.; Chen K.-C.; Hsu K.-H.; Tseng J.-S.; Ho C.-C.; Hsia T.-C.; Su K.-Y.; Wu M.-F.; Chiu K.-L.; Liu C.-M.; Wu T.-C.; Chen H.-J.; Chen H.-Y.; Chang C.-S.; Hsu C.-P.; Hsia J.-Y.; Chuang C.-Y.; Lin C.-H.; Chen J.J.W.; Chen K.-Y.; Liao W.-Y.; Shih J.-Y.; Yu S.-L.; Yu C.-J.; Pan-Chyr Yang; Yang T.-Y.; Chang G.-C.; Tseng C.-H.; PAN-CHYR YANG et al. |
| 臺大學術典藏 |
2020-12-02T02:33:23Z |
Coexistence of EGFR T790M mutation and common activating mutations in pretreatment non-small cell lung cancer: A systematic review and meta-analysis
|
Chen L.-Y.; Molina-Vila M.A.; Ruan S.-Y.; Su K.-Y.; Liao W.-Y.; Yu K.-L.; Ho C.-C.; Shih J.-Y.; Yu C.-J.; Yang J.C.H.; Rosell R.; Pan-Chyr Yang; Chen L.-Y.; PAN-CHYR YANG et al. |
| 臺大學術典藏 |
2020-12-02T02:33:12Z |
Epidermal growth factor receptor mutation predicts favorable outcomes in non-small cell lung cancer patients with brain metastases treated with stereotactic radiosurgery
|
Yang W.-C.; Xiao F.; Shih J.-Y.; Ho C.-C.; Chen Y.-F.; Tseng H.-M.; Chen K.-Y.; Liao W.-Y.; Yu C.-J.; Yang J.C.-H.; Kuo S.-H.; Cheng J.C.-H.; PAN-CHYR YANG; Hsu F.-M. |
| 臺大學術典藏 |
2020-12-02T02:33:11Z |
Trajectories of caregiver burden and related factors in family caregivers of patients with lung cancer
|
Lee Y.-H.; Liao Y.-C.; Shun S.-C.; Lin K.-C.; Liao W.-Y.; Chang P.-H.; Jhang S.-Y.; Yu C.-J.; PAN-CHYR YANG; Hsieh P.-Y.; Lai Y.-H. |
| 臺大學術典藏 |
2020-09-28T08:03:39Z |
Pneumothorax in the ICU: Patient outcomes and prognostic factors
|
Chen K.-Y.; JIH-SHUIN JERNG; Liao W.-Y.; Ding L.-W.; Kuo L.-C.; Wang J.-Y.; Yang P.-C. |
| 臺大學術典藏 |
2020-09-28T08:03:38Z |
Value of imprint cytology for ultrasound-guided transthoracic core biopsy
|
Liao W.-Y.; JIH-SHUIN JERNG; Chen K.-Y.; Chang Y.-L.; Yang P.-C.; Kuo S.-H. |
| 臺大學術典藏 |
2020-09-23T08:35:42Z |
Epidermal growth factor receptor mutation predicts favorable outcomes in non-small cell lung cancer patients with brain metastases treated with stereotactic radiosurgery
|
Yang W.-C.;Xiao F.;Shih J.-Y.;Ho C.-C.;Ya-Fang Chen;Tseng H.-M.;Chen K.-Y.;Liao W.-Y.;Yu C.-J.;Yang J.C.-H.;Kuo S.-H.;Cheng J.C.-H.;Yang P.-C.;Hsu F.-M.; Yang W.-C.; Xiao F.; Shih J.-Y.; Ho C.-C.; YA-FANG CHEN; Tseng H.-M.; Chen K.-Y.; Liao W.-Y.; Yu C.-J.; Yang J.C.-H.; Kuo S.-H.; Cheng J.C.-H.; Yang P.-C.; Hsu F.-M. |
| 臺大學術典藏 |
2020-08-13T06:33:47Z |
Neoadjuvant chemotherapy with docetaxel-cisplatin in patients with stage III N2 non-small-cell lung cancer
|
Yang J.C.-H.; Ho C.-C.; Chen K.-Y.; JIN-YUAN SHIH; Wu M.; Chen J.-H.; Liao W.-Y.; Yu C.-J. |
| 臺大學術典藏 |
2020-08-13T06:33:47Z |
Survival of lung adenocarcinoma patients with malignant pleural effusion
|
Wu S.-G.; Yu C.-J.; Tsai M.-F.; Liao W.-Y.; Yang C.-H.; Jan I.-S.; Yang P.-C.; JIN-YUAN SHIH |
| 臺大學術典藏 |
2020-08-13T06:33:43Z |
Identification of Five Driver Gene Mutations in Patients with Treatment-Na?ve Lung Adenocarcinoma in Taiwan
|
Yang T.-Y.; Chiu K.-L.; Hsu K.-H.; Ho C.-C.; Hsia T.-C.; Tseng J.-S.; Su K.-Y.; Wu M.-F.; Chang G.-C.; Yang P.-C.; Yu C.-J.; Chen K.-C.; Ooi H.; Wu T.-C.; Chen H.-J.; Chen H.-Y.; Chang C.-S.; Hsu C.-P.; Hsia J.-Y.; Chuang C.-Y.; Lin C.-H.; Chen J.J.W.; Chen K.-Y.; Liao W.-Y.; JIN-YUAN SHIH; Yu S.-L. |
| 臺大學術典藏 |
2020-08-13T06:33:42Z |
Discordant HER2 Exon 20 mutation status determines a differential sensitivity to Afatinib
|
Gow C.-H.; Liao W.-Y.; Liu Y.-N.; JIN-YUAN SHIH |
| 臺大學術典藏 |
2020-08-13T06:33:39Z |
Coexistence of EGFR T790M mutation and common activating mutations in pretreatment non-small cell lung cancer: A systematic review and meta-analysis
|
Chen L.-Y.;Molina-Vila M.A.;Ruan S.-Y.;Su K.-Y.;Liao W.-Y.;Yu K.-L.;Ho C.-C.;Jin-Yuan Shih;Yu C.-J.;Yang J.C.H.;Rosell R.;Yang P.-C.; Chen L.-Y.; Molina-Vila M.A.; Ruan S.-Y.; Su K.-Y.; Liao W.-Y.; Yu K.-L.; Ho C.-C.; JIN-YUAN SHIH; Yu C.-J.; Yang J.C.H.; Rosell R.; Yang P.-C. |
| 臺大學術典藏 |
2020-08-13T06:33:33Z |
Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study
|
Yang J.C.-H.; Thress K.S.; Huang D.D.-R.; Bai Y.-Y.; Chang Y.-L.; Hsieh M.-S.; Su K.-Y.; Tsai T.-H.; Lee J.-H.; Liao W.-Y.; Ho C.-C.; Lin C.-C.; JIN-YUAN SHIH; Yu C.-J.; Lin C.-C.;Jin-Yuan Shih;Yu C.-J.;Ho C.-C.;Liao W.-Y.;Lee J.-H.;Tsai T.-H.;Su K.-Y.;Hsieh M.-S.;Chang Y.-L.;Bai Y.-Y.;Huang D.D.-R.;Thress K.S.;Yang J.C.-H. |
| 臺大學術典藏 |
2020-08-13T06:33:33Z |
Epidermal growth factor receptor mutation predicts favorable outcomes in non-small cell lung cancer patients with brain metastases treated with stereotactic radiosurgery
|
Chen K.-Y.; Liao W.-Y.; Yu C.-J.; Yang J.C.-H.; Kuo S.-H.; Cheng J.C.-H.; Yang P.-C.; Hsu F.-M.; Tseng H.-M.; Chen Y.-F.; Yang W.-C.; Xiao F.; JIN-YUAN SHIH; Ho C.-C.; Yang W.-C.;Xiao F.;Jin-Yuan Shih;Ho C.-C.;Chen Y.-F.;Tseng H.-M.;Chen K.-Y.;Liao W.-Y.;Yu C.-J.;Yang J.C.-H.;Kuo S.-H.;Cheng J.C.-H.;Yang P.-C.;Hsu F.-M. |
| 臺大學術典藏 |
2020-08-13T06:33:33Z |
Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan
|
Yang J.C.; Yu C.-J.; JIN-YUAN SHIH; Lin C.-C.; Tsai T.-H.; Hsu C.-L.; Hsu W.-H.; Su K.-Y.; Chang Y.-L.; Lee J.-H.; Chen K.-Y.; Liao W.-Y.; Lin S.-Y.;Yang C.-Y.;Liao B.-C.;Ho C.-C.;Liao W.-Y.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Hsu W.-H.;Su K.-Y.;Chang Y.-L.;Lee J.-H.;Lin C.-C.;Jin-Yuan Shih;Yang J.C.;Yu C.-J.; Lin S.-Y.; Yang C.-Y.; Liao B.-C.; Ho C.-C. |
| 臺大學術典藏 |
2020-08-13T06:33:32Z |
Combined effect of ERCC1 and ERCC2 polymorphisms on overall survival in non-squamous non-small-cell lung cancer patients treated with first-line pemetrexed/platinum
|
Yu C.-J.; JIN-YUAN SHIH; Liao W.-Y.;Ho C.-C.;Tsai T.-H.;Chen K.-Y.;Jin-Yuan Shih;Yu C.-J.; Liao W.-Y.; Ho C.-C.; Tsai T.-H.; Chen K.-Y. |
| 臺大學術典藏 |
2020-08-13T06:33:31Z |
Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study
|
Liang S.-K.;Lee M.-R.;Liao W.-Y.;Ho C.-C.;Ko J.-C.;Jin-Yuan Shih; Liang S.-K.; Lee M.-R.; Liao W.-Y.; Ho C.-C.; Ko J.-C.; JIN-YUAN SHIH |
| 臺大學術典藏 |
2020-08-13T06:33:31Z |
Best Response According to RECIST During First-line EGFR-TKI Treatment Predicts Survival in EGFR Mutation-positive Non–Small-cell Lung Cancer Patients
|
Ho C.-C.; JIN-YUAN SHIH; Yu C.-J.; Yang J.C.-H.; Liao W.-Y.; Lin C.-C.; Lee J.-H.; Hsiue E.H.-C.; Wu T.-H.; Wu T.-H.;Hsiue E.H.-C.;Lee J.-H.;Lin C.-C.;Liao W.-Y.;Ho C.-C.;Jin-Yuan Shih;Yu C.-J.;Yang J.C.-H. |
| 臺大學術典藏 |
2020-08-13T06:33:29Z |
Activity of Afatinib in Heavily Pretreated Patients With ERBB2 Mutation–Positive Advanced NSCLC: Findings From a Global Named Patient Use Program
|
Spataro V.; Unk M.; Chih-Hsin Yang J.; Lorence R.M.; Carri?re P.; Cseh A.; Chang G.-C.; Gautschi O.; Liao W.-Y.; Peters S.;Curioni-Fontecedro A.;Nechushtan H.;Jin-Yuan Shih;Liao W.-Y.;Gautschi O.;Spataro V.;Unk M.;Chih-Hsin Yang J.;Lorence R.M.;Carri?Re P.;Cseh A.;Chang G.-C.; Peters S.; Curioni-Fontecedro A.; Nechushtan H.; JIN-YUAN SHIH |
| 臺大學術典藏 |
2020-08-13T06:33:29Z |
The value of radial endobronchial ultrasound-guided bronchial brushing in peripheral non-squamous non-small cell lung cancer
|
Yu K.-L.;Tsai T.-H.;Ho C.-C.;Liao W.-Y.;Lin C.-K.;Hsu C.-L.;Jin-Yuan Shih; Yu K.-L.; Tsai T.-H.; Ho C.-C.; Liao W.-Y.; Lin C.-K.; Hsu C.-L.; JIN-YUAN SHIH |
| 臺大學術典藏 |
2020-08-13T06:33:28Z |
Consecutive emergence of typical acquired resistance to EGFR tyrosine kinase inhibitors in a patient with metastatic pulmonary squamous cell carcinoma
|
Yang C.-Y.; Hsieh M.-S.; Liao W.-Y.; JIN-YUAN SHIH; Yu C.-J. |
| 臺大學術典藏 |
2020-08-13T06:33:27Z |
Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations
|
Yang J.C.-H.; Yu C.-J.; JIN-YUAN SHIH; Lin Z.-Z.; Lin Y.-T.; Chen J.-S.; Liao W.-Y.; Ho C.-C.; Hsu C.-L.; Yang C.-Y.; Chen K.-Y.; Lee J.-H. |
| 臺大學術典藏 |
2020-08-13T06:33:24Z |
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors
|
Tsai T.-H.; Chen K.-Y.; Ho C.-C.; Liao W.-Y.; Yang C.-Y.; Yang C.-Y.;Liao W.-Y.;Ho C.-C.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Su K.-Y.;Chang Y.-L.;Wu C.-T.;Hsu C.-C.;Liao B.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Jin-Yuan Shih;Yang J.C.-H.;Yu C.-J.; Hsu C.-L.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; JIN-YUAN SHIH; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2020-08-13T06:33:24Z |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
Yu C.-J.; Yang J.C.-H.; JIN-YUAN SHIH; Lin C.-C.; Lee J.-H.; Hsu W.-H.; Liu Y.-N.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu C.-L.; Yang C.-Y.;Liao W.-Y.;Ho C.-C.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Liu Y.-N.;Su K.-Y.;Chang Y.-L.;Wu C.-T.;Liao B.-C.;Hsu C.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Jin-Yuan Shih;Yang J.C.-H.;Yu C.-J.; Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H. |
| 臺大學術典藏 |
2020-08-13T05:24:15Z |
Multi-gene analyses from waste brushing specimens for patients with peripheral lung cancer receiving EBUS-assisted bronchoscopy
|
Yang C.-Y.; Tsai T.-H.; Ho C.-C.; Liao W.-Y.; Jan I.-S.; Chen K.-Y.; JANN-YUAN WANG; Ruan S.-Y.; Yu C.-J.; Yang J.C.H.; Yang P.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2020-08-12T08:25:26Z |
Survival of lung adenocarcinoma patients with malignant pleural effusion
|
Shang-Gin Wu;Yu C.-J.;Tsai M.-F.;Liao W.-Y.;Yang C.-H.;Jan I.-S.;Yang P.-C.;Shih J.-Y.; SHANG-GIN WU; Yu C.-J.; Tsai M.-F.; Liao W.-Y.; Yang C.-H.; Jan I.-S.; Yang P.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2020-08-12T07:57:22Z |
Risk Factors of Pneumothorax after Endobronchial Ultrasound-Guided Transbronchial Biopsy for Peripheral Lung Lesions
|
Huang C.-T.;Sheng-Yuan Ruan;Liao W.-Y.;Kuo Y.-W.;Lin C.-Y.;Tsai Y.-J.;Ho C.-C.;Yu C.-J.; Huang C.-T.; SHENG-YUAN RUAN; Liao W.-Y.; Kuo Y.-W.; Lin C.-Y.; Tsai Y.-J.; Ho C.-C.; Yu C.-J. |
| 臺大學術典藏 |
2020-08-12T07:57:21Z |
Multi-gene analyses from waste brushing specimens for patients with peripheral lung cancer receiving EBUS-assisted bronchoscopy
|
Tsai T.-H.; Yang C.-Y.; Ho C.-C.; Liao W.-Y.; Jan I.-S.; Chen K.-Y.; Wang J.-Y.; SHENG-YUAN RUAN; Yu C.-J.; Yang J.C.H.; Yang P.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2020-08-12T07:57:16Z |
Coexistence of EGFR T790M mutation and common activating mutations in pretreatment non-small cell lung cancer: A systematic review and meta-analysis
|
Chen L.-Y.; Molina-Vila M.A.; SHENG-YUAN RUAN; Su K.-Y.; Liao W.-Y.; Yu K.-L.; Ho C.-C.; Shih J.-Y.; Yu C.-J.; Yang J.C.H.; Rosell R.; Yang P.-C. |
| 臺大學術典藏 |
2020-08-12T06:35:18Z |
Symptoms, psychological distress, and supportive care needs in lung cancer patients
|
Liao Y.-C. ;Liao W.-Y. ;Shun S.-C. ;Chong-Jen Yu ;Yang P.-C. ;Lai Y.-H.; Liao Y.-C.; Liao W.-Y.; Shun S.-C.; CHONG-JEN YU; Yang P.-C.; Lai Y.-H. |
| 臺大學術典藏 |
2020-08-12T06:35:07Z |
Survival of lung adenocarcinoma patients with malignant pleural effusion
|
Wu S.-G.;Chong-Jen Yu;Tsai M.-F.;Liao W.-Y.;Yang C.-H.;Jan I.-S.;Yang P.-C.;Shih J.-Y.; Wu S.-G.; CHONG-JEN YU; Tsai M.-F.; Liao W.-Y.; Yang C.-H.; Jan I.-S.; Yang P.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2020-08-12T06:34:40Z |
Prospective evaluation of procalcitonin, soluble triggering receptor expressed on myeloid cells-1 and c-reactive protein in febrile patients with autoimmune diseases
|
CHONG-JEN YU; Hsieh S.-C.; Keng L.-T.; Lee H.-S.; Chang H.-T.; Liao W.-Y.; Ho C.-C.; Lin C.-H. |
| 臺大學術典藏 |
2020-08-12T06:34:29Z |
Real-world data on prognostic factors for overall survival in EGFR mutation-positive advanced non-small cell lung cancer patients treated with first-line gefitinib
|
Chen J.-S.; Lin Z.-Z.; Lin C.-C.; Yang J.C.H.; CHONG-JEN YU; Chen K.-Y.; Shih J.-Y.; Ho C.-C.; Liao W.-Y.; Yao Z.-H.; Yao Z.-H.;Liao W.-Y.;Ho C.-C.;Chen K.-Y.;Shih J.-Y.;Chen J.-S.;Lin Z.-Z.;Lin C.-C.;Yang J.C.H.;Chong-Jen Yu |
| 臺大學術典藏 |
2020-08-12T06:34:19Z |
Incidence of hepatitis B reactivation during epidermal growth factor receptor tyrosine kinase inhibitor treatment in non–small-cell lung cancer patients
|
Ho C.-C.; Chen K.-Y.; Shih J.-Y.; Chen J.-S.; Lin Z.-Z.; Lin C.-C.; Yang J.C.-H.; CHONG-JEN YU; Liao W.-Y.; Yao Z.-H.; Yao Z.-H.;Liao W.-Y.;Ho C.-C.;Chen K.-Y.;Shih J.-Y.;Chen J.-S.;Lin Z.-Z.;Lin C.-C.;Yang J.C.-H.;Chong-Jen Yu |
| 臺大學術典藏 |
2020-08-12T06:34:19Z |
Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations
|
Lin Y.-T.;Chen J.-S.;Liao W.-Y.;Ho C.-C.;Hsu C.-L.;Yang C.-Y.;Chen K.-Y.;Lee J.-H.;Lin Z.-Z.;Shih J.-Y.;Yang J.C.-H.;Chong-Jen Yu; Ho C.-C.; Hsu C.-L.; Yang C.-Y.; Chen K.-Y.; Lee J.-H.; Lin Z.-Z.; Shih J.-Y.; Yang J.C.-H.; CHONG-JEN YU; Lin Y.-T.; Chen J.-S.; Liao W.-Y. |
| 臺大學術典藏 |
2020-08-12T06:34:15Z |
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors
|
Hsu C.-C.; Wu C.-T.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Su K.-Y.; Chang Y.-L.; Yang C.-Y.; Yang C.-Y.;Liao W.-Y.;Ho C.-C.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Su K.-Y.;Chang Y.-L.;Wu C.-T.;Hsu C.-C.;Liao B.-C.;Hsu W.-H.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.-H.;Chong-Jen Yu; Liao B.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; CHONG-JEN YU |
| 臺大學術典藏 |
2020-08-12T06:34:13Z |
Autophagy in fibroblasts induced by cigarette smoke extract promotes invasion in lung cancer cells
|
CHONG-JEN YU; Lee C.-H.; Liao W.-Y.; Pan H.-J.; Hou H.-H.; Hou H.-H.;Pan H.-J.;Liao W.-Y.;Lee C.-H.;Chong-Jen Yu |
| 臺大學術典藏 |
2020-08-12T02:50:56Z |
TREM-1 expression in tumor-associated macrophages and clinical outcome in lung cancer
|
CHAO-CHI HO; Liao W.-Y.; Wang C.-Y.; Lu Y.-H.; Huang H.-Y.; Chen H.-Y.; Chan W.-K.; Chen H.-W.; Yang P.-C. |
| 臺大學術典藏 |
2020-08-12T02:50:46Z |
Coexistence of EGFR T790M mutation and common activating mutations in pretreatment non-small cell lung cancer: A systematic review and meta-analysis
|
Shih J.-Y.; CHAO-CHI HO; Yu K.-L.; Chen L.-Y.;Molina-Vila M.A.;Ruan S.-Y.;Su K.-Y.;Liao W.-Y.;Yu K.-L.;Chao-Chi Ho;Shih J.-Y.;Yu C.-J.;Yang J.C.H.;Rosell R.;Yang P.-C.; Chen L.-Y.; Molina-Vila M.A.; Ruan S.-Y.; Su K.-Y.; Liao W.-Y.; Yu C.-J.; Yang J.C.H.; Rosell R.; Yang P.-C. |
| 臺大學術典藏 |
2020-08-12T02:50:43Z |
Acquired BRAF V600E Mutation as Resistant Mechanism after Treatment with Osimertinib
|
Chao-Chi Ho;Liao W.-Y.;Lin C.-A.;Shih J.-Y.;Yu C.-J.;Chih-Hsin Yang J.; CHAO-CHI HO; Liao W.-Y.; Lin C.-A.; Shih J.-Y.; Yu C.-J.; Chih-Hsin Yang J. |
| 臺大學術典藏 |
2020-08-12T02:50:42Z |
Real-world data on prognostic factors for overall survival in EGFR mutation-positive advanced non-small cell lung cancer patients treated with first-line gefitinib
|
Lin C.-C.; Yang J.C.H.; Yu C.-J.; Lin Z.-Z.; Chen J.-S.; Yao Z.-H.; Liao W.-Y.; CHAO-CHI HO; Chen K.-Y.; Shih J.-Y.; Yao Z.-H.;Liao W.-Y.;Chao-Chi Ho;Chen K.-Y.;Shih J.-Y.;Chen J.-S.;Lin Z.-Z.;Lin C.-C.;Yang J.C.H.;Yu C.-J. |
| 臺大學術典藏 |
2020-08-12T02:50:41Z |
Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan
|
Lin S.-Y.;Yang C.-Y.;Liao B.-C.;Chao-Chi Ho;Liao W.-Y.;Chen K.-Y.;Tsai T.-H.;Hsu C.-L.;Hsu W.-H.;Su K.-Y.;Chang Y.-L.;Lee J.-H.;Lin C.-C.;Shih J.-Y.;Yang J.C.;Yu C.-J.; Lin S.-Y.; Yang C.-Y.; Liao B.-C.; CHAO-CHI HO; Liao W.-Y.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Hsu W.-H.; Su K.-Y.; Chang Y.-L.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.; Yu C.-J. |
